Changes in mesenteric vascular reactivity and inflammatory response after cardiopulmonary bypass in a rat model

Annals of Thoracic Surgery

Volumn 77, Issue 6, 2004, Pages 2130-2137

  Doguet, Fabien ^a   Litzler, Pierre Yves ^b   Tamion, Fabienne ^b   Richard, Vincent ^b   Hellot, Marie France ^b   Thuillez, Christian ^b   Tabley, Alfred ^b   Bouchart, François ^b   Bessou, Jean Paul ^b  

^a HÔPITAL CHARLES NICOLLE   (France)

^b NONE

Author keywords

25

Indexed keywords

ACETYLCHOLINE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; ARTICLE; BLOOD GAS PARAMETERS; BLOOD SAMPLING; BLOOD VESSEL REACTIVITY; CANNULATION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMORAL ARTERY; HEMODYNAMIC MONITORING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY INFILTRATE; LUNG INFILTRATE; MALE; MESENTERIC ARTERY; MESENTERY BLOOD VESSEL; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SURGICAL TECHNIQUE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ACETYLCHOLINE; ANIMALS; ARTERIOLES; CARDIOPULMONARY BYPASS; ILEUM; MALE; MESENTERIC ARTERIES; MESENTERIC VASCULAR OCCLUSION; NITROARGININE; NITROPRUSSIDE; PHENYLEPHRINE; RATS; RATS, WISTAR; SPLANCHNIC CIRCULATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 2542441412     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.10.034     Document Type: Article

References (23)

1. Sibbald W.J. Cardiopulmonary bypass and intestinal and pulmonary endothelial permeability a need for understanding. Chest. 108:1995;598-599
2. Sinclair D.G., Haslam P.L., Quinlan G.J., Pepper J.R., Evans W.T. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest. 108:1995;718-724
3. Hill G.E., Whitten C.W., Landers D.F. The influence of cardiopulmonary bypass on cytokines and cell-cell communication. J Cardiothorac Vasc Anesth. 11:1997;367-375
4. Galea J., Rebuck N., Finn A., Manché A., Moat N. Expression of soluble endothelial adhesion molecules in clinical cardiopulmonary bypass. Perfusion. 13:1998;314-321
5. Verrier E.D., Morgan E.N. Endothelial response to cardiopulmonary bypass surgery. Ann Thorac Surg. 66:1998;S17-19
6. Menasche P., Peynet J., Haeffner-Cavaillon N., et al. Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass. Circulation. 92:(suppl 9):1995;II334-340
7. Jansen N.J.G., Van Oeveren W., Gu Y.J., Van Vliet M.H., Eijsman L., Wildevuur C.R.H. Endotoxin release ant tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg. 54:1992;744-748
8. Cremer J., Martin M., Redl H., et al. Systemic inflammatory response after cardiac operations. Ann Thorac Surg. 61:1996;1714-1720
9. Ohri S.K., Becket J., Brannan J., Keogh B.E., Taylor K.M. Effects of cardiopulmonary bypass on gut blood flow, oxygen utilization, and intramucosal pH. Ann Thorac Surg. 57:1994;1193-1199
10. Niederhäuser U., Genoni M., Von Segesser L.K., Brühlmann W., Turina M.I. Mesenteric ischemia after a cardiac operation conservative treatment with local vasodilation. Ann Thorac Surg. 61:1996;1817-1819
11. Ott M.J., Buchman T.G., Baumgartner W.A. Postoperative abdominal complications in cardiopulmonary bypass patients a case-controlled study. Ann Thorac Surg. 59:1995;1210-1213
12. Ohri S.K. Systemic inflammatory response and the splanchnic bed in cardiopulmonary bypass. Perfusion. 11:1996;200-212
13. Albes J.M., Schistek R., Baier R., Unger F. Intestinal ischemia associated with cardiopulmonary bypass surgery a life threatening complication. J Cardiovasc Surg. 32:1991;527-533
14. Ohri S.K., Bjarnason I., Pathi V., et al. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg. 55:1993;1080-1086
15. Cox C.S., Allen S.J. Jr, Brennan M. Analysis of intestinal microvascular permeability associated with cardiopulmonary bypass. J Surg Res. 83:1999;19-26
16. Biffl W.L., Moore E.E. Splanchnic ischaemia/reperfusion and multiple organ failure. Br J Anaesth. 77:1996;59-70
17. Parks D.A., Granger D.N. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol. 250:(Pt 1):1986;G749-753
18. Tofukuji M., Stahl G.L., Metais C., et al. Mesenteric dysfunction after cardiopulmonary bypass role of complement C5a. Ann Thorac Surg. 69:2000;799-807
19. Fabre O., Zegdi R., Vincentelli A., et al. A recovery model of cardiopulmonary bypass in rat. Perfusion. 16:2001;215-220
20. Gu J., Mariani M.A., Boonstra P.W., Grandjean J.G., van Oeveren W. Complement activation in coronary artery bypass grafting patients without cardiopulmonary bypass. Chest. 116:1999;892-898
21. Kirshbom P.M., Jacobs M.T., Tsui S.S.L., et al. Effects of cardiopulmonary bypass and circulatory arrest on endothelium-dependant vasodilatation in the lung. J Thorac Cardiovasc Surg. 111:1996;1248-1256
22. Cooper W.A., Duarte I.G., Thourani V.H., et al. Hypothermic circulatory arrest causes multisystem vascular endothelial dysfunction and apoptosis. Ann Thorac Surg. 69:2000;696-703
23. O'Dwyer C., Woodson L.C., Conroy B.P., et al. Regional perfusion abnormalities with phenylephrine during normothermic bypass. Ann Thorac Surg. 63:1997;728-735